Biomea Fusion, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
BMEA$0.60+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Operations and Comprehensive Loss
(in thousands, except share and per share data)
| Year Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Operating expenses: | |||
| Research and development | $118,085 | $102,546 | $62,713 |
| General and administrative | 25,985 | 23,589 | 20,921 |
| Total operating expenses | 144,070 | 126,135 | 83,634 |
| Loss from operations | (144,070) | (126,135) | (83,634) |
| Interest and other income, net | 5,644 | 8,880 | 1,806 |
| Net loss | $(138,426) | $(117,255) | $(81,828) |
| Other comprehensive loss: | |||
| Unrealized gain on investments, net | — | 1 | 9 |
| Comprehensive loss | $(138,426) | $(117,254) | $(81,819) |
| Net loss per common share, basic and diluted | $(3.83) | $(3.44) | $(2.80) |
| Weighted-average number of common shares used to compute basic and diluted net loss per common share | 36,105,671 | 34,106,923 | 29,271,777 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.